Xilio Therapeutics, Inc.XLONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-17.58M
↑ 62% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthStrong
Average
$-45.91M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-17.58M | +4.5% |
| 2024 | $-18.41M | +73.4% |
| 2023 | $-69.11M | +10.9% |
| 2022 | $-77.59M | +5.2% |
| 2021 | $-81.85M | -113.8% |
| 2020 | $-38.28M | -106.3% |
| 2019 | $-18.56M | - |